Gara Jalqabaatti › Kansarii Ovarii › Florida › Miami
Qorannoo klinikaalii Kansarii Ovarii Miami, FL keessatti
Qorannoo 23 Kansarii Ovarii f Miami fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Genoma Research, Inc., Miami
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Sylvester Comprehensive Cancer Center, Miami
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Namoota walitti qabaa jiraSadarkaa 2
- Sylvester Comprehensive Cancer Center, Miami
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Namoota walitti qabaa jiraSadarkaa 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Miami Sylvester Comprehensive Cancer Center, Miami
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Miami, Miami
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Namoota walitti qabaa jiraSadarkaa 3
- Mt. Sinai Comprehensive Cancer Center, Miami
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Namoota walitti qabaa jira
- Jackson Memorial Hospital-Holtz Children's Hospital, Miami
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
Namoota walitti qabaa jiraSadarkaa 4
- University of Miami, Miami
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Sylvester Cancer Center, Miami
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Namoota walitti qabaa jiraSadarkaa 2
- University of Miami Hospital and Clinics, Miami
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
Namoota walitti qabaa jira
- University of Miami, Miami
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Miami, Miami
- Biogenix, Miami
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Miami Hospital and Clinics, Miami
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Sylvester Comprehensive Cancer Center, Univ of Miami Miller School of Medicine, Miami
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Miami Hospital and Clinics, Miami
- Miami Cancer Institute, Miami
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Namoota walitti qabaa jira
- University of Miami, Miami
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Miami Cancer Institute, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Miami
Qorannoo Kansarii Ovarii magaalota biroo keessatti
- Houston, TXQorannoo 89
- New York City, NYQorannoo 69
- Boston, MAQorannoo 61
- Los Angeles, CAQorannoo 50
- Nashville, TNQorannoo 49
- Arlington, VAQorannoo 46
- Philadelphia, PAQorannoo 44
- Columbus, OHQorannoo 39
- St. Louis, MOQorannoo 38
- Chicago, ILQorannoo 36
- San Antonio, TXQorannoo 31
- Cleveland, OHQorannoo 30
Qorannoo biroo Miami keessatti
- Saree OljooQorannoo 42
- Saree (Gosoota Hunda)Qorannoo 36
- Kansara Qara'a Non-Small CellQorannoo 31
- Kansarii ProstateQorannoo 27
- ObesityQorannoo 27
- Leukemia Myeloidii HamaaQorannoo 24
- Kansara MetastatikiiQorannoo 24
- Baayyee UlfaataaQorannoo 23
- Myeloma Baay’eeQorannoo 21
- Colitis UlcerativeQorannoo 21
- Dhukkubaa AlzheimerQorannoo 20
- Dhibee QaraQorannoo 20
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.